Download:
pdf |
pdfPrint Date: 3/11/21
Title:
NCEHATSDR Service Delivery (Generic Clearance)
Project Id:
0900f3eb81cc43d8
Accession #:
-NCEH-3/10/21-c43d8
Project Contact:
Abel_Jason A. (jza5)
Organization:
NCEH/ATSDR
Status:
Pending Regulatory Clearance
Intended Use:
Project Determination
Estimated Start Date:
02/01/2022
Estimated Completion Date:
01/31/2025
CDC/ATSDR HRPO/IRB Protocol #:
NA
OMB Control #:
0923-0047
Determinations
Determination
Justification
Completed
Entered By & Role
3/11/21
Davis_Stephanie I. (sgd8) CIO HSC
Not Research / Other
HSC:
Does NOT Require HRPO
Review
45 CFR 46.102(l)
Program Evaluation
Quality Assurance / Improvement
Other - Service Delivery and Program Improvement
PRA:
PRA Applies
3/11/21
Davis_Stephanie I. (sgd8) CIO OMB / PRA
Description & Funding
Description
Priority:
Standard
Determination Start Date:
03/10/21
Description:
This is a request to publish the 60-day Federal Register Notice for ATSDR #Generic Clearance for the Collection of Qualitative
Feedback on Agency Service Delivery# (OMB Control No. 0923-0047; expiration date 01/31/2022). The information collection
activity provides a means to garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with
the Federal government#s commitment to improving service delivery. By qualitative feedback we mean information that provides
useful insights on perceptions and opinions, but are not statistical surveys that yield quantitative results that can be generalized to
the population of study.
IMS/CIO/Epi-Aid/Chemical Exposure Submission:
No
IMS Activation Name:
Not selected
Primary Priority of the Project:
Not selected
Secondary Priority(s) of the Project:
Not selected
Task Force Associated with the Response:
Not selected
CIO Emergency Response Name:
Not selected
Epi-Aid Name:
Not selected
Assessment of Chemical Exposure Name:
Not selected
Goals/Purpose
This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early
warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve
delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between the
Agency and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program
management.
Objective:
The solicitation of feedback will target areas such as: timeliness, appropriateness, accuracy of information, courtesy, efficiency of
service delivery, and resolution of issues with service delivery. Responses will be assessed to plan and inform efforts to improve or
maintain the quality of service offered to the public. If this information is not collected, vital feedback from customers and
stakeholders on the Agency#s services will be unavailable.
Activities or Tasks:
New Collection of Information, Data, or Biospecimens
Target Populations to be Included/Represented:
General US Population
Tags/Keywords:
Feedback
CDC's Role:
Activity originated and designed by CDC staff, or conducted at the specific request of CDC, or CDC staff will approve study design
and data collection as a condition of any funding provided, CDC employees or agents will obtain data by intervening or interacting
with participants, CDC employees or agents will obtain or use anonymous or unlinked data or biological specimens, CDC
employees or agents will obtain or use identifiable (including coded) private data or biological specimens, CDC employees will
participate as co-authors in presentation(s) or publication(s), CDC employees will provide substantial technical assistance or
oversight
Method Categories:
Discussion Group; Focus Group; Individual Interviews (Qualitative); Needs Assessment; QA/QI
Methods:
ATSDR will only submit a collection for approval under this generic clearance if it meets the following conditions: # The collections
are voluntary; # The collections are low-burden for respondents (based on considerations of total burden hours, total number of
respondents, or burden-hours per respondent) and are low-cost for both the respondents and the Federal Government; # The
collections are noncontroversial and do not raise issues of concern to other Federal agencies; # Any collection is targeted to the
solicitation of opinions from respondents who have experience with the program or may have experience with the program in the
near future; # Personally identifiable information (PII) is collected only to the extent necessary and is not retained; # Information
gathered is intended to be used only internally for general service improvement and program management purposes and is not
intended for release outside of the agency (if released, the agency must indicate the qualitative nature of the information); #
Information gathered will not be used for the purpose of substantially informing influential policy decisions; and # Information
gathered will yield qualitative information; the collections will not be designed or expected to yield statistically reliable results or used
as though the results are generalizable to the population of study.
Collection of Info, Data or Biospecimen:
The types of collections that this generic clearance covers include, but are not limited to: # Customer comment cards/complaint
forms # Small discussion groups # Focus Groups of customers, potential customers, delivery partners, or other stakeholders #
Cognitive laboratory studies, such as those used to refine questions or assess usability of a website; # Qualitative customer
satisfaction surveys (e.g., post-transaction surveys; opt-out web surveys) # In-person observation testing (e.g., website or software
usability tests)
Expected Use of Findings/Results:
The solicitation of feedback will target areas such as: timeliness, appropriateness, accuracy of information, courtesy, efficiency of
service delivery, and resolution of issues with service delivery. Responses will be assessed to plan and inform efforts to improve or
maintain the quality of service offered to the public. If this information is not collected, vital feedback from customers and
stakeholders on the Agency#s services will be unavailable.
Could Individuals potentially be identified based on
Information Collected?
Yes
Will PII be captured (including coded data)?
Yes
Does CDC have access to the identifiers?
Yes
Is an assurance of confidentiality in place or
planned?
No
Is a certificate of confidentiality in place or planned? No
Is there a formal written agreement prohibiting the
release of identifiers?
No
Funding
Funding Type
Funding Title
Other-Staff time only - $0
Staff time only - $0
HSC Review
HSC Attributes
Program Evaluation
Yes
Quality Assurance / Improvement
Yes
Other - Service Delivery and Program Improvement
Yes
Additional Ethical Considerations
Resulting data collected are not published but will be
used to improve agency products.
Regulation and Policy
Do you anticipate this project will be submitted to
the IRB office
Estimated number of study participants
Population - Children
Population - Minors
Population - Prisoners
Population - Pregnant Women
No
Funding #
Original Budget Yr
# Years Award
Population - Emancipated Minors
Suggested level of risk to subjects Do you anticipate this project will be exempt research or non-exempt research
Requested consent process waviers
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Alteration of authorization under HIPPA Privacy
Rule
No Selection
Requested Waivers of Documentation of Informed Consent
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Consent process shown in an understandable language
Reading level has been estimated
No Selection
Comprehension tool is provided
No Selection
Short form is provided
No Selection
Translation planned or performed
No Selection
Certified translation / translator
No Selection
Translation and back-translation to/from target
language(s)
No Selection
Other method
No Selection
Clinical Trial
Involves human participants
No Selection
Assigned to an intervention
No Selection
Evaluate the effect of the intervention
No Selection
Evaluation of a health related biomedical or
behavioral outcome
No Selection
Registerable clinical trial
No Selection
Other Considerations
Exception is requested to PHS informing those
bested about HIV serostatus
No Selection
Human genetic testing is planned now or in the
future
No Selection
Involves long-term storage of identfiable biological
specimens
No Selection
Involves a drug, biologic, or device
No Selection
Conducted under an Investigational New Drug
exemption or Investigational Device Exemption
No Selection
Institutions & Staff
Institutions
Institutions yet to be added .....
Staff
Staff
Member
SIQT
Exp. Date
CITI Biomedical
Exp. Date
CITI Social &
Behavioral Exp. Date
CITI Good Clinical
Practice Exp. Date
Stephanie
Davis
02/22
/2024
10/24/2021
08/03/2021
08/15/2014
Data
DMP
Proposed Data Collection Start Date:
2/1/22
Proposed Data Collection End Date:
1/31/25
Proposed Public Access Level:
Non-Public
Staff Role
Email
Phone
Organization
Data Use
Contact
sgd8@cdc.
gov
770-4883676
NATIONAL CENTER FOR
ENVIRONMENTAL HEALTH
Non-Public Details:
Reason For Not Releasing Data:
Other - Quality improvement for ATSDR services
Public Access Justification:
This is a generic IC request to allow gathering of feedback on services provided by ATSDR for the purposes of quality improvement.
How Access Will Be Provided for Data:
Data will be used by ATSDR to evaluate and improve services.
Plans for Archival and Long Term Preservation:
Spatiality
Spatiality (Geographic Locations) yet to be added .....
Dataset
Dataset
Title
Dataset
Description
Dataset yet to be added...
Data Publisher
/Owner
Public Access
Level
Public Access
Justification
External
Access URL
Download
URL
Type of Data
Released
Collection
Start Date
Collection End
Date
File Type | application/pdf |
File Modified | 0000-00-00 |
File Created | 2021-03-11 |